| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 143,534 | 130,779 | 121,110 | 131,155 | | Cost of Revenue | 30,771 | 28,184 | 24,374 | 24,808 | | | Gross Profit | 112,763 | 102,595 | 96,736 | 106,347 | | | Operating Expenses | | Research Development | 35,527 | 32,371 | 50,542 | 30,484 | | Selling General and Administrative | 31,740 | 34,319 | 30,407 | 30,013 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 45,496 | 35,905 | 15,787 | 45,850 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,123 | 885 | 1,076 | (46,864) | | Earnings Before Interest And Taxes | 46,619 | 36,790 | 16,863 | (1,014) | | Interest Expense | 5,293 | 5,175 | 5,108 | 2,020 | | Income Before Tax | 41,326 | 31,615 | 11,755 | (3,034) | | Income Tax Expense | 15,947 | 7,839 | 3,979 | (126,069) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,379 | 23,776 | 7,776 | 123,035 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,379 | 23,776 | 7,776 | 123,035 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,379 | $23,776 | $7,776 | $123,035 |
|
0.51% Nasdaq 
Income Statement
